Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Cancer and the workplace

Preventing cancer in the EU through legislation, education and taxation

Obesity and tobacco use increasing global cancer burden

Lessening the global financial burden of cancer

Research reproducibility and scientific ecosystems

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche

Economics of radiation therapy

Can early stage NSCLC be treated with stereotactic radiation therapy?

Stereotactic radiation therapy for oligmetastases

Can SBRT be of use for early, operable non-small cell lung cancer?

Investigating genetic vulnerabilities to radiation therapy